WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 08 2019
Historique:
received: 10 10 2018
accepted: 19 07 2019
entrez: 11 8 2019
pubmed: 11 8 2019
medline: 18 12 2019
Statut: epublish

Résumé

Cardiac fibrosis is a final common pathology in inherited and acquired heart diseases that causes cardiac electrical and pump failure. Here, we use systems genetics to identify a pro-fibrotic gene network in the diseased heart and show that this network is regulated by the E3 ubiquitin ligase WWP2, specifically by the WWP2-N terminal isoform. Importantly, the WWP2-regulated pro-fibrotic gene network is conserved across different cardiac diseases characterized by fibrosis: human and murine dilated cardiomyopathy and repaired tetralogy of Fallot. Transgenic mice lacking the N-terminal region of the WWP2 protein show improved cardiac function and reduced myocardial fibrosis in response to pressure overload or myocardial infarction. In primary cardiac fibroblasts, WWP2 positively regulates the expression of pro-fibrotic markers and extracellular matrix genes. TGFβ1 stimulation promotes nuclear translocation of the WWP2 isoforms containing the N-terminal region and their interaction with SMAD2. WWP2 mediates the TGFβ1-induced nucleocytoplasmic shuttling and transcriptional activity of SMAD2.

Identifiants

pubmed: 31399586
doi: 10.1038/s41467-019-11551-9
pii: 10.1038/s41467-019-11551-9
pmc: PMC6689010
doi:

Substances chimiques

Extracellular Matrix Proteins 0
Protein Isoforms 0
Smad2 Protein 0
Smad2 protein, mouse 0
Transforming Growth Factor beta 0
betaIG-H3 protein 148710-76-3
Wwp2 protein, mouse EC 2.3.2.26
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3616

Subventions

Organisme : British Heart Foundation
ID : SP/10/10/28431
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U120097112
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/11/25/28740
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/15/5/31446
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1992027/7163
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U120085815
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Genetics. 2011 Dec;189(4):1449-59
pubmed: 21926303
Cardiovasc Res. 2000 May;46(2):307-15
pubmed: 10773235
Brief Funct Genomics. 2014 Jan;13(1):66-78
pubmed: 23960099
Cardiovasc Res. 2013 Mar 15;97(4):653-65
pubmed: 23118132
Eur Heart J. 2010 May;31(10):1188-96
pubmed: 20031959
J Clin Invest. 2005 Mar;115(3):599-609
pubmed: 15711638
J Clin Invest. 2017 Oct 2;127(10):3770-3783
pubmed: 28891814
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
Int J Sports Med. 2018 Apr;39(4):314-321
pubmed: 29534260
JAMA. 2013 Mar 6;309(9):896-908
pubmed: 23462786
Curr Cancer Drug Targets. 2011 Mar;11(3):347-56
pubmed: 21247385
EMBO J. 2011 Nov 01;30(23):4777-89
pubmed: 22045334
Matrix Biol. 2018 Aug;68-69:8-27
pubmed: 29355590
Bioinformatics. 2009 Nov 1;25(21):2780-6
pubmed: 19689953
Nature. 2010 Sep 23;467(7314):460-4
pubmed: 20827270
Heart Fail Clin. 2018 Apr;14(2):139-146
pubmed: 29525643
Nat Cell Biol. 2011 Sep 25;13(11):1368-75
pubmed: 21947082
Circ Res. 2016 Mar 18;118(6):1021-40
pubmed: 26987915
Nat Commun. 2015 Jan 23;6:6031
pubmed: 25615886
Nat Cell Biol. 2011 Jan;13(1):59-65
pubmed: 21170031
Nat Cell Biol. 2011 Jun;13(6):728-33
pubmed: 21532586
Nature. 2017 Dec 7;552(7683):110-115
pubmed: 29160304
Mol Cell Biol. 2005 Nov;25(22):9845-58
pubmed: 16260601
Bioinformatics. 2010 Oct 1;26(19):2438-44
pubmed: 20709693
Nat Rev Mol Cell Biol. 2004 Mar;5(3):209-19
pubmed: 14991001
Nat Genet. 2005 Mar;37(3):243-53
pubmed: 15711544
BMC Bioinformatics. 2007 Jun 25;8:220
pubmed: 17592643
Methods Mol Biol. 2017;1488:337-362
pubmed: 27933533
Genome Res. 2014 Jun;24(6):942-53
pubmed: 24793478
Nat Genet. 2008 May;40(5):546-52
pubmed: 18443592
N Engl J Med. 2015 Mar 19;372(12):1138-49
pubmed: 25785971
Cell. 2007 Jan 12;128(1):141-56
pubmed: 17218261
J Biol Chem. 2003 Sep 19;278(38):35857-60
pubmed: 12860974
J Cardiovasc Pharmacol. 2011 Apr;57(4):376-9
pubmed: 21297493
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5115-20
pubmed: 23479606
Oncoscience. 2014 Nov 28;1(12):807-20
pubmed: 25621296
Genome Biol. 2017 Sep 14;18(1):170
pubmed: 28903782
Cell Immunol. 2016 Aug-Sep;306-307:1-8
pubmed: 27406900
Nat Genet. 2008 Aug;40(8):952-4
pubmed: 18587397
JCI Insight. 2016 May 5;1(6):
pubmed: 27239561
Cell Res. 2016 Apr;26(4):484-98
pubmed: 27002218
Nat Genet. 2018 Dec;50(12):1681-1687
pubmed: 30374069
EMBO J. 2000 Apr 17;19(8):1745-54
pubmed: 10775259
Oncol Rep. 2017 Aug;38(2):933-940
pubmed: 28627672
Sci Transl Med. 2018 Apr 11;10(436):
pubmed: 29643228
Cells. 2014 Oct 15;3(4):981-93
pubmed: 25317929
Biomater Res. 2016 May 25;20:13
pubmed: 27226899
Eur J Heart Fail. 2017 Feb;19(2):177-191
pubmed: 28157267
Mol Cell. 2002 Aug;10(2):283-94
pubmed: 12191474
J Biol Chem. 2007 Aug 3;282(31):22804-15
pubmed: 17500067
Front Med (Lausanne). 2015 Sep 03;2:59
pubmed: 26389119
J Invest Dermatol. 2015 Jul;135(7):1893-1902
pubmed: 25739049
J Cell Biol. 2011 Aug 8;194(3):355-65
pubmed: 21825071
Cell Res. 2009 Jan;19(1):36-46
pubmed: 19114992
Oncogene. 2011 May 26;30(21):2451-62
pubmed: 21258410
Nat Commun. 2011;2:251
pubmed: 21427722
Cardiovasc Res. 2007 May 1;74(2):207-12
pubmed: 16919613
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6614-9
pubmed: 17420471
Cell Biosci. 2011 Dec 28;1(1):43
pubmed: 22204598
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Fibrogenesis Tissue Repair. 2011 Feb 01;4(1):4
pubmed: 21284856
PLoS One. 2017 Jul 27;12(7):e0181945
pubmed: 28750100
Int J Biochem Cell Biol. 2008;40(3):383-408
pubmed: 18061509
Cell Rep. 2014 Aug 21;8(4):1210-24
pubmed: 25131209
Nat Med. 2015 Sep;21(9):998-1009
pubmed: 26236991
Basic Res Cardiol. 2013 Jan;108(1):316
pubmed: 23197152
Dev Dyn. 2010 Jun;239(6):1573-84
pubmed: 20503355
Circ Res. 2010 Jun 11;106(11):1675-80
pubmed: 20538689
Mol Pharmacol. 2002 Jul;62(1):65-74
pubmed: 12065756
Nat Cell Biol. 1999 Dec;1(8):472-8
pubmed: 10587642
JCI Insight. 2017 May 4;2(9):
pubmed: 28469078
Nat Rev Genet. 2011 Sep 07;12(10):671-82
pubmed: 21897427
Cardiovasc Pathol. 2016 May-Jun;25(3):225-231
pubmed: 26938796
J Cardiovasc Transl Res. 2013 Dec;6(6):931-44
pubmed: 23929067
Am J Physiol Heart Circ Physiol. 2013 Jun 15;304(12):H1719-26
pubmed: 23585135
Heart Fail Rev. 2014 Mar;19(2):173-85
pubmed: 23124941
J Biol Chem. 2015 Oct 16;290(42):25427-38
pubmed: 26318453
Cardiovasc Ther. 2012 Feb;30(1):e30-40
pubmed: 21883991
Circ Res. 2015 Mar 27;116(7):1269-76
pubmed: 25814687

Auteurs

Huimei Chen (H)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Aida Moreno-Moral (A)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Francesco Pesce (F)

Department of Emergency and Organ Transplantation (DETO), University of Bari, 70124, Bari, Italy.

Nithya Devapragash (N)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Massimiliano Mancini (M)

SOC di Anatomia Patologica, Ospedale San Giovanni di Dio, 50123, Florence, Italy.

Ee Ling Heng (EL)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.

Maxime Rotival (M)

Unit of Human Evolutionary Genetics, Institute Pasteur, 75015, Paris, France.

Prashant K Srivastava (PK)

Division of Brain Sciences, Imperial College Faculty of Medicine, London, W12 0NN, UK.

Nathan Harmston (N)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Kirill Shkura (K)

Division of Brain Sciences, Imperial College Faculty of Medicine, London, W12 0NN, UK.

Owen J L Rackham (OJL)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Wei-Ping Yu (WP)

Animal Gene Editing Laboratory, BRC, A*STAR20 Biopolis Way, Singapore, 138668, Republic of Singapore.
Institute of Molecular and Cell Biology, A*STAR, 61 Biopolis Drive, Singapore, 138673, Republic of Singapore.

Xi-Ming Sun (XM)

MRC London Institute of Medical Sciences (LMC), Imperial College, London, W12 0NN, UK.

Nicole Gui Zhen Tee (NGZ)

National Heart Centre Singapore, Singapore, 169609, Republic of Singapore.

Elisabeth Li Sa Tan (ELS)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.

Paul J R Barton (PJR)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Cardiovascular Research Centre, Royal Brompton and Harefield NHS Trust, London, SW3 6NP, UK.

Leanne E Felkin (LE)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Cardiovascular Research Centre, Royal Brompton and Harefield NHS Trust, London, SW3 6NP, UK.

Enrique Lara-Pezzi (E)

Centro Nacional de Investigaciones Cardiovasculares - CNIC, 28029, Madrid, Spain.

Gianni Angelini (G)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Bristol Heart Institute, Bristol Medical School, University of Bristol, Bristol, BS2 89HW, UK.

Cristina Beltrami (C)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.

Michal Pravenec (M)

Institute of Physiology, Czech Academy of Sciences, 142 00, Praha 4, Czech Republic.

Sebastian Schafer (S)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.
National Heart Centre Singapore, Singapore, 169609, Republic of Singapore.

Leonardo Bottolo (L)

Department of Medical Genetics, University of Cambridge, Cambridge, CB2 0QQ, UK.
The Alan Turing Institute, London, NW1 2DB, UK.
MRC Biostatistics Unit, University of Cambridge, Cambridge, CB2 0SR, UK.

Norbert Hubner (N)

Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 13347, Berlin, Germany.
Charité-Universitätsmedizin, 10117, Berlin, Germany.
Berlin Institute of Health (BIH), 10178, Berlin, Germany.

Costanza Emanueli (C)

National Heart and Lung Institute, Imperial College London, London, SW7 2AZ, UK.
Cardiovascular Research Centre, Royal Brompton and Harefield NHS Trust, London, SW3 6NP, UK.

Stuart A Cook (SA)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.
MRC London Institute of Medical Sciences (LMC), Imperial College, London, W12 0NN, UK.
National Heart Centre Singapore, Singapore, 169609, Republic of Singapore.

Enrico Petretto (E)

Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore. enrico.petretto@duke-nus.edu.sg.
MRC London Institute of Medical Sciences (LMC), Imperial College, London, W12 0NN, UK. enrico.petretto@duke-nus.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH